Prognostic value of late gadolinium enhancement in nonischemic cardiomyopathy
Abstract
The purpose of this study was to determine the prognostic value of late gadolinium enhancement seen on cardiac magnetic resonance (CMR) imaging in patients with nonischemic cardiomyopathy (NICMP). Patients with NICMP are at increased risk for cardiovascular events and death.
Meta-analysis of the usefulness of change in QRS width to predict response to cardiac resynchronization therapy
Abstract
The existing data regarding the role of QRS duration (QRSd) change on cardiac resynchronization therapy (CRT) response show some inconsistent results. We conducted a meta-analysis of data obtained from observational studies to examine the impact of QRS change after CRT
Renal denervation, the opinion of the cardiologist
Abstract
New invasive technology looks very promising, as they allow you to discontinue the drug with serious side effects. Efficacy and safety procedures for the method have been studied in the pioneering research in terms of process engineering. The effects of renal denervation
Role of melatonin in patients with acute coronary syndrome
Abstract
The available data on melatonin production in acute coronary syndrome are known to be contradictory. Its role in the human body is not quite clear either. However, some of its properties have been convincingly proved. Melatonin has been shown to produce vivid effect on
Evolocumab: innovative opportunities for LDL-C AND LP (a) lowering and cardiovascular risk management
Abstract
Despite proven effectiveness of statin therapy the target values of low density lipoproteins (LDL-C) are often not achieved on the therapy, especially in high- and very high-risk patients. Patients with statin intolerance and patients with familial hypercholesterolemia are
Experimental and clinical studies of staphylokinase and Fortelyzin®
Abstract
The article presents experimental and pilot clinical studies of staphylokinase as the most fibrin-selective thrombolytic. It was shown a high efficacy and safety of bolus-infusion usage of staphylokinase compared to Actilyse® in patients with myocardial infarction with
Masks of hypertrophic cardiomyopathy - acromegaly
Abstract
Hypertrophic cardiomyopathy (HCM) refer to non-coronarogenic diseases and has a prevalence of 0.3-0.5 cases per 100 000 annually. Up to 60% of all HCM cases have autosomal dominant mode of inheritance and only a small part (less than 5%) have endocrine base. In the article
Successive surgical treatment of atrial flutter in patient with Wolf-Parkinson-White syndrome
Abstract
Two clinical examples of the rare form of the combination of Wolff-Parkinson-White (WPW) syndrome and atrial flutter are presented. Patients with previously diagnosed WPW syndrome delayed surgical treatment for a long time, due to rare and short arrhythmia paroxysms. The
Arterial hypertension management in patients aged older than 80 years and patients with the senile asthenia
Abstract
A position agreement of the experts of Russian association of gerontologists and geriatricians, Gerontological society of Russian Academy of Sciences, Russian medical society for arterial hypertensio n Task Force Members: Tkacheva O.N. (Chairperson), Runikhina N.K.,
Dilated cardiomyopathy: differential diagnosis, approaches to therapy, surgical treatment
Abstract
Dilated cardiomyopathy (DCM) - the disease which is characterized by a left ventricular dilatation with development of a systolic heart failure and isn't bound to coronary heart disease or valvular dysfunction. The risk of DCM development at the age of more senior than 40
High-technology chronic heart failure therapeutic interventions
Abstract
Chronic heart failure (CHF) is one of the most severe and prognostically unfavorable complications of cardiovascular diseases. Over the past 30 years average duration of life for patients with such diagnosis has increased from 3.5 to 8 years (in comparison with the period